NKTR-171: A novel, oral, sodium channel blocker that exhibits comparable analgesic efficacy to pregabalin with reduced Central Nervous System (CNS) side effects

Authors :: P. Quach
S. Harrison
I. Choi
W. Rubas
G. Kim
B. Deng
R. Jaladi
M. Guillon
S. Doberstein
J. Riggs-Sauthier
H. Gursahani
K. Gogas
J. Evans
Source :: The Journal of Pain. 14:S57
Publication Year :: 2013
Publisher :: Elsevier BV, 2013.

Subjects :: business.industry
Central nervous system
Analgesic
Pregabalin
Pharmacology
Anesthesiology and Pain Medicine
medicine.anatomical_structure
Neurology
Anesthesia
medicine
Channel blocker
Neurology (clinical)
Oral sodium
business
medicine.drug

Full Text Access

Tools